FAMS 2.0 for Type 2 Diabetes (FAMS 2 Trial)

"While there is data that supports the safety of FAMS 2.0, there isn't any evidence to suggest it has an effective application yet, so our team at Power assigned a score of 2 on a 1-3 scale."

"Clinicaltrials.gov states that this trial is not presently recruiting patients, despite having initially been posted on April 28th 2020 and most recently edited on November 28th 2022. Fortunately, there are 1284 other studies currently enrolling volunteers from the public."

"The primary objective of this investigation, which will be evaluated during a baseline visit and again 6 and 9 months later, is to assess the long-term psychosocial well-being of patients. Secondary goals include quantifying any changes in support burden (as measured by DAWN2) for family members, as well as diabetes distress experienced by those same loved ones both during intervention period and beyond. Each metric is scored from 0 to 100 - with higher scores denoting increased levels of stress or strain."

"The qualifications for this medical trial are individuals aged between 18 and 75. Those under the age of 18 can choose from 188 different studies, while 964 trials accept participants over 65 years old."

"This clinical trial is recruiting 334 individuals with type 2 diabetes mellitus, aged 18-75. Crucially, they must possess the following qualifications: Be literate in English, Have a positive diagnosis of type 2 diabetes, Receive treatment from an affiliated clinic or hospital, Live independently (i.e., not in long term care), Take at least one daily medication for diabetes management, Own a mobile phone and be over 18 years old."